Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements

被引:68
作者
Abdalla, Eddie K. [1 ]
Bauer, Todd W. [2 ]
Chun, Yun S. [3 ]
D'Angelica, Michael [4 ]
Kooby, David A. [5 ]
Jarnagin, William R. [4 ]
机构
[1] Lebanese Amer Univ, Dept Surg, Beirut, Lebanon
[2] Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA USA
[3] Fox Chase Canc Ctr, Dept Surg Oncol, Philadelphia, PA 19111 USA
[4] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA
[5] Emory Univ Sch Med, Dept Surg, Atlanta, GA USA
关键词
HEPATIC ARTERIAL INFUSION; POSITRON-EMISSION-TOMOGRAPHY; IRINOTECAN-ELUTING BEADS; LONG-TERM SURVIVAL; PHASE-I TRIAL; RADIOFREQUENCY ABLATION; SYSTEMIC CHEMOTHERAPY; RANDOMIZED-TRIAL; NEOADJUVANT CHEMOTHERAPY; MULTIINSTITUTIONAL ANALYSIS;
D O I
10.1111/j.1477-2574.2012.00597.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Selection of the optimal surgical and interventional therapies for advanced colorectal cancer liver metastases (CRLM) requires multidisciplinary discussion of treatment strategies early in the trajectory of the individual patient's care. This paper reports on expert consensus on locoregional and interventional therapies for the treatment of advanced CRLM. Resection remains the reference treatment for patients with bilateral CRLM and synchronous presentation of primary and metastatic cancer. Patients with oligonodular bilateral CRLM may be candidates for one-stage multiple segmentectomies; two-stage resection with or without portal vein embolization may allow complete resection in patients with more advanced disease. After downsizing with preoperative systemic and/or regional therapy, curative-intent hepatectomy requires resection of all initial and currently known sites of disease; debulking procedures are not recommended. Many patients with synchronous primary disease and CRLM can safely undergo simultaneous resection of all disease. Staged resections should be considered for patients in whom the volume of the future liver remnant is anticipated to be marginal or inadequate, who have significant medical comorbid condition(s), or in whom extensive resections are required for the primary cancer and/or CRLM. Priority for liver-first or primary-first resection should depend on primary tumour-related symptoms or concern for the progression of marginally resectable CRLM during treatment of the primary disease. Chemotherapy delivered by hepatic arterial infusion represents a valid option in patients with liver-only disease, although it is best delivered in experienced centres. Ablation strategies are not recommended as first-line treatments for resectable CRLM alone or in combination with resection because of high local failure rates and limitations related to tumour size, multiplicity and intrahepatic location.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 117 条
[1]   Improving resectability of hepatic colorectal metastases: Expert consensus statement [J].
Abdalla, Eddie K. ;
Adam, Rene ;
Bilchik, Anton J. ;
Jaeck, Daniel ;
Vauthey, Jean-Nicolas ;
Mahvi, David .
ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (10) :1271-1280
[2]  
Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
[3]  
ACKERMAN NB, 1974, SURGERY, V75, P589
[4]   Tumor progression while on chemotherapy - A contraindication to liver resection for multiple colorectal metastases? [J].
Adam, R ;
Pascal, G ;
Castaing, D ;
Azoulay, D ;
Delvart, V ;
Paule, B ;
Levi, F ;
Bismuth, H .
ANNALS OF SURGERY, 2004, 240 (06) :1052-1064
[5]  
Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16
[6]   Repeat hepatectomy for colorectal liver metastases [J].
Adam, R ;
Bismuth, H ;
Castaing, D ;
Waechter, F ;
Navarro, F ;
Abascal, A ;
Majno, P ;
Engerran, L .
ANNALS OF SURGERY, 1997, 225 (01) :51-60
[7]   Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases [J].
Adam, Rene ;
Miller, Rafael ;
Pitombo, Marcos ;
Wicherts, Dennis A. ;
de Haas, Robbert J. ;
Bitsakou, Georgia ;
Aloia, Thomas .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 16 (03) :525-+
[8]   Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure? [J].
Adam, Rene ;
Wicherts, Dennis A. ;
de Haas, Robbert J. ;
Ciacio, Oriana ;
Levi, Francis ;
Paule, Bernard ;
Ducreux, Michel ;
Azoulay, Daniel ;
Bismuth, Henri ;
Castaing, Denis .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) :1829-1835
[9]   Alternating Systemic and Hepatic Artery Infusion Therapy for Resected Liver Metastases From Colorectal Cancer: A North Central Cancer Treatment Group (NCCTG)/National Surgical Adjuvant Breast and Bowel Project (NSABP) Phase II Intergroup Trial, N9945/CI-66 [J].
Alberts, Steven R. ;
Roh, Mark S. ;
Mahoney, Michelle R. ;
O'Connell, Michael J. ;
Nagorney, David M. ;
Wagman, Lawrence ;
Smyrk, Thomas C. ;
Weiland, Timothy L. ;
Lai, Lily Lau ;
Schwarz, Roderich E. ;
Molina, Roy ;
Dentchev, Todor ;
Bolton, John S. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) :853-858
[10]  
Aliberti C, 2006, ANTICANCER RES, V26, P3793